1. Drent, M. L., Larsson, I., William-Olsson, T., Quaade, F., Czubayko, F., Von Bergmann, K., Strobel, W., Sjostrom, L., and Van Der Veen, E. A., Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int. J. Obes. Relat. Metab. Disord., 19, 221–226 (1995).
2. Ferguson, R., Actubudua arguta — the hardy kiwifruit. New Zealand Kiwifruit, 81, 23–24 (1991).
3. Gargouri, Y., Ransac, S., and Verger, R., Covalent inhibition of digestive lipases: an in vitro study. Biochim. Biophys. Acta., 1344, 6–37 (1997).
4. Girotti, C., Ginet, M., Demarne, F. C., Lagarde, M., and Geloen, A., Lipolytic activity of cirsimarin extracted from Microtea debilis. Planta Med., 71, 1170–1172 (2005).
5. Hartz, A. J., Rupley, D. C., Jr., Kalkhoff, R. D., and Rimm, A. A., Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev. Med., 12, 351–357 (1983).